NCT06581770

Brief Summary

The World Health Organization (WHO) defines digital health as the field of knowledge and application related to any aspect of the adoption of digital technology in the stages of improvement. The combination of digital health with technology brings about a new transformation in digital media. This transformation allows for the development of communication and information in health services, the ability to conduct health-related research on digital media and the evaluation of this data. The ease of access to information and the provision of a timely feedback mechanism in the face of problems have enabled the spread of digital health systems, and have also enabled chronic disease management and epidemic disease monitoring. It is recommended that the term digital readiness be used to cover the combination of digital access and use, digital literacy and digital health literacy. Digital health readiness is also defined as the main determinant of health and is thought to contribute to the improvement of health processes with the development of digital health literacy and to be a useful solution against health problems that may arise in the follow-up of chronic diseases. Although there are tools in the literature that evaluate digital health readiness, there is no Turkish assessment tool that facilitates the follow-up of non-communicable chronic diseases. Therefore, the aim of our study is to evaluate the translation, validity, and reliability of the Digital Health Readiness Questionaire into Turkish in individuals with chronic non-infectious diseases.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 30, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 3, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

October 15, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2025

Completed
Last Updated

February 10, 2025

Status Verified

February 1, 2025

Enrollment Period

6 months

First QC Date

August 30, 2024

Last Update Submit

February 5, 2025

Conditions

Keywords

digital healthDigital Health Readiness Questionaire

Outcome Measures

Primary Outcomes (1)

  • Translation of the digital health readiness questionnaire

    Translation of the digital health readiness questionnaire into Turkish and application on the sample

    1 month

Secondary Outcomes (1)

  • the validity and reliability of the survey in Turkish

    11 months

Interventions

It is a validity and reliability study that can evaluate digital health readiness.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This study aimed to include 200 participants who applied as patients to Istanbul Faculty of Medicine, Department of Internal Medical Sciences, Department of Internal Medicine, Diabetes and Obesity Polyclinic and Istanbul Florence Nightingale Hospital, Department of Cardiovascular Surgery between September 2024 and August 2025 and met the inclusion criteria, based on the ethics committee approvals obtained from Biruni University Clinical Research Ethics Committee, decision number 2015-KAEK-68-22-01 dated 28.07.2022, and the ethics committee approvals obtained from Biruni University Non-Interventional Clinical Research Ethics Committee, decision number 2023/85-65 dated 22.12.2023.

You may qualify if:

  • The study will include people over the age of 18, native Turkish speakers, literate, obese, diabetic, cardiovascular and respiratory patients.

You may not qualify if:

  • Individuals with insufficient cooperation (Mini Mental Test score \<24) and any cognitive problems that may prevent the administration of the survey will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Biruni University

Istanbul, Istanbul, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Noncommunicable Diseases

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Busra Ulker Eksi

CONTACT

Buket Akinci

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
2 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher

Study Record Dates

First Submitted

August 30, 2024

First Posted

September 3, 2024

Study Start

October 15, 2024

Primary Completion

April 15, 2025

Study Completion

September 15, 2025

Last Updated

February 10, 2025

Record last verified: 2025-02

Locations